RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype
Enhanced cholesterol biosynthesis is associated with cancer progression. Here the authors identify the nuclear receptor RORγ as a novel master regulator of cholesterol metabolism in triple negative breast cancer (TNBC) and find that RORγ small-molecule antagonists induce tumor regression in patient-...
Guardado en:
Autores principales: | Demin Cai, Junjian Wang, Bei Gao, Jin Li, Feng Wu, June X. Zou, Jianzhen Xu, Yuqian Jiang, Hongye Zou, Zenghong Huang, Alexander D. Borowsky, Richard J. Bold, Primo N. Lara, Jian Jian Li, Xinbin Chen, Kit S. Lam, Ka-Fai To, Hsing-Jien Kung, Oliver Fiehn, Ruqian Zhao, Ronald M. Evans, Hong-Wu Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/985e83249405455e850f73d41a842e97 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ROR1 and ROR2 expression in pancreatic cancer
por: Dongli Liu, et al.
Publicado: (2021) -
Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534
por: Xiaohua Xue, et al.
Publicado: (2021) -
Sumoylation of RORγt regulates TH17 differentiation and thymocyte development
por: Zhiheng He, et al.
Publicado: (2018) -
RORα Enhances Lysosomal Acidification and Autophagic Flux in the Hepatocytes
por: Hyeon‐Ji Kim, et al.
Publicado: (2021) -
SOX-5 activates a novel RORγt enhancer to facilitate experimental autoimmune encephalomyelitis by promoting Th17 cell differentiation
por: Yi Tian, et al.
Publicado: (2021)